基于外泌体的免疫疗法。
Exosome-based immunotherapy.
作者信息
Chaput Nathalie, Taïeb Julien, Schartz Noël E C, André Fabrice, Angevin Eric, Zitvogel Laurence
机构信息
ERIT-M 02-08 INSERM, Department of Clinical Biology, Institut Gustave Roussy (IGR), 39 rue Camille Desmoulins, 94805, Villejuif, France.
出版信息
Cancer Immunol Immunother. 2004 Mar;53(3):234-9. doi: 10.1007/s00262-003-0472-x. Epub 2004 Jan 16.
Abstract
Exosomes are small membrane vesicles originating from late endosomes and secreted by hematopoietic and epithelial cells in culture. Exosome proteic and lipid composition is unique and might shed some light into exosome biogenesis and function. Exosomes secreted from professional antigen-presenting cells (i.e., B lymphocytes and dendritic cells) are enriched in MHC class I and II complexes, costimulatory molecules, and hsp70-90 chaperones, and have therefore been more extensively studied for their immunomodulatory capacities in vitro and in vivo. This review will present the main biological features pertaining to tumor or DC-derived exosomes, will emphasize their immunostimulatory function, and will discuss their implementation in cancer immunotherapy.
摘要
外泌体是源自晚期内体的小膜泡，由培养中的造血细胞和上皮细胞分泌。外泌体的蛋白质和脂质组成独特，可能有助于揭示外泌体的生物发生和功能。专业抗原呈递细胞（即B淋巴细胞和树突状细胞）分泌的外泌体富含MHC I类和II类复合物、共刺激分子和hsp70 - 90伴侣蛋白，因此在体外和体内的免疫调节能力方面得到了更广泛的研究。本综述将介绍与肿瘤或树突状细胞衍生的外泌体相关的主要生物学特征，强调其免疫刺激功能，并讨论它们在癌症免疫治疗中的应用。
相似文献
1
Exosome-based immunotherapy.基于外泌体的免疫疗法。
Cancer Immunol Immunother. 2004 Mar;53(3):234-9. doi: 10.1007/s00262-003-0472-x. Epub 2004 Jan 16.
2
Exosomes for immunotherapy of cancer.用于癌症免疫治疗的外泌体。
Adv Exp Med Biol. 2003;532:215-21. doi: 10.1007/978-1-4615-0081-0_17.
3
[Exosomes and anti-tumour immunotherapy].[外泌体与抗肿瘤免疫治疗]
Bull Cancer. 2003 Aug-Sep;90(8-9):695-8.
4
Cancer immunotherapy using dendritic cell-derived exosomes.使用树突状细胞衍生外泌体的癌症免疫疗法。
Medicina (B Aires). 2000;60 Suppl 2:51-4.
5
Prospects for exosomes in immunotherapy of cancer.外泌体在癌症免疫治疗中的前景。
J Cell Mol Med. 2006 Apr-Jun;10(2):376-88. doi: 10.1111/j.1582-4934.2006.tb00406.x.
6
[Exosome: Trojan horse in immunotherapy].[外泌体：免疫治疗中的特洛伊木马]
Sheng Li Ke Xue Jin Zhan. 2005 Apr;36(2):113-8.
7
[Exosomes derived from dendritic cells].[源自树突状细胞的外泌体]
J Soc Biol. 2001;195(1):25-7.
8
The potential of exosomes in immunotherapy.外泌体在免疫治疗中的潜力。
Expert Opin Biol Ther. 2005 Jun;5(6):737-47. doi: 10.1517/14712598.5.6.737.
9
Review: cancer immunotherapy by exosome-based vaccines.综述：基于外泌体的疫苗用于癌症免疫治疗
Cancer Biother Radiopharm. 2007 Oct;22(5):692-703. doi: 10.1089/cbr.2007.368-R.
10
Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.外泌体作为有效的无细胞肽基疫苗。I. 树突状细胞衍生的外泌体将功能性MHC I类/肽复合物转移至树突状细胞。
J Immunol. 2004 Feb 15;172(4):2126-36. doi: 10.4049/jimmunol.172.4.2126.
引用本文的文献
1
Extracellular Vesicles in Sport Horses: Potential Biomarkers and Modulators of Exercise Adaptation and Therapeutics.运动马匹中的细胞外囊泡：运动适应与治疗的潜在生物标志物和调节剂
Int J Mol Sci. 2025 May 3;26(9):4359. doi: 10.3390/ijms26094359.
2
The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes.肿瘤微环境（TME）在推进癌症治疗中的作用：免疫系统相互作用、肿瘤浸润淋巴细胞（TILs）以及外泌体和炎性小体的作用
Int J Mol Sci. 2025 Mar 18;26(6):2716. doi: 10.3390/ijms26062716.
3
Potential Effect of Extracellular Vesicles in Clinical Settings of Lymphoma.细胞外囊泡在淋巴瘤临床环境中的潜在作用。
Indian J Clin Biochem. 2025 Jan;40(1):12-24. doi: 10.1007/s12291-023-01156-x. Epub 2023 Oct 14.
4
Immunomodulatory effects of immune cell-derived extracellular vesicles in melanoma.免疫细胞来源的细胞外囊泡在黑色素瘤中的免疫调节作用。
Front Immunol. 2024 Sep 26;15:1442573. doi: 10.3389/fimmu.2024.1442573. eCollection 2024.
5
Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder.人脐带间充质干细胞外泌体的治疗作用及其在炎症性肠病和其他炎症性疾病中的广泛治疗意义。
Front Med (Lausanne). 2024 Jul 30;11:1406547. doi: 10.3389/fmed.2024.1406547. eCollection 2024.
6
Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis.外泌体作为肾细胞癌治疗、诊断和预后的新型工具。
Heliyon. 2024 Jun 13;10(12):e32875. doi: 10.1016/j.heliyon.2024.e32875. eCollection 2024 Jun 30.
7
Exosome may be the next generation of promising cell-free vaccines.外泌体可能是下一代有前途的无细胞疫苗。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2345940. doi: 10.1080/21645515.2024.2345940. Epub 2024 May 7.
8
Application of exosomes in tumor immunity: recent progresses.外泌体在肿瘤免疫中的应用：最新进展
Front Cell Dev Biol. 2024 Apr 3;12:1372847. doi: 10.3389/fcell.2024.1372847. eCollection 2024.
9
The implications of exosomes in psoriasis: disease: emerging as new diagnostic markers and therapeutic targets.外泌体在银屑病中的意义：疾病：新兴的诊断标志物和治疗靶点。
Mol Biol Rep. 2024 Mar 29;51(1):465. doi: 10.1007/s11033-024-09449-x.
10
Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.利用外泌体作为急性髓系白血病的临床生物标志物和治疗反应的触发因素。
Front Immunol. 2024 Jan 16;14:1315453. doi: 10.3389/fimmu.2023.1315453. eCollection 2023.
本文引用的文献
1
Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes.树突状细胞衍生的外泌体对初始CD4+ T细胞的间接激活。
Nat Immunol. 2002 Dec;3(12):1156-62. doi: 10.1038/ni854. Epub 2002 Nov 11.
2
Production and characterization of clinical grade exosomes derived from dendritic cells.源自树突状细胞的临床级外泌体的生产与特性分析
J Immunol Methods. 2002 Dec 15;270(2):211-26. doi: 10.1016/s0022-1759(02)00330-7.
3
Exosomes: composition, biogenesis and function.外泌体：组成、生物发生及功能
Nat Rev Immunol. 2002 Aug;2(8):569-79. doi: 10.1038/nri855.
4
Malignant effusions and immunogenic tumour-derived exosomes.恶性积液与免疫原性肿瘤衍生外泌体
Lancet. 2002 Jul 27;360(9329):295-305. doi: 10.1016/S0140-6736(02)09552-1.
5
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.肿瘤衍生的外泌体是用于细胞毒性T淋巴细胞（CTL）交叉启动的共享肿瘤排斥抗原的来源。
Nat Med. 2001 Mar;7(3):297-303. doi: 10.1038/85438.
6
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.注射未成熟树突状细胞后对人类效应T细胞功能的抗原特异性抑制。
J Exp Med. 2001 Jan 15;193(2):233-8. doi: 10.1084/jem.193.2.233.
7
Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes.肥大细胞依赖性B和T淋巴细胞的激活是由具有免疫活性的外泌体分泌介导的。
J Immunol. 2001 Jan 15;166(2):868-76. doi: 10.4049/jimmunol.166.2.868.
8
Characteristics of the interaction between Hsc70 and the transferrin receptor in exosomes released during reticulocyte maturation.网织红细胞成熟过程中释放的外泌体中Hsc70与转铁蛋白受体之间相互作用的特征
J Biol Chem. 2001 Mar 30;276(13):9910-6. doi: 10.1074/jbc.M009641200. Epub 2000 Dec 22.
9
Exosome: from internal vesicle of the multivesicular body to intercellular signaling device.外泌体：从多囊泡体的内部囊泡到细胞间信号传导装置。
J Cell Sci. 2000 Oct;113 Pt 19:3365-74. doi: 10.1242/jcs.113.19.3365.
10
Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface.滤泡树突状细胞在其表面携带表达MHC II类分子的微囊泡。
J Immunol. 2000 Aug 1;165(3):1259-65. doi: 10.4049/jimmunol.165.3.1259.
Zotero 插件